The restoration of public health webpages has reignited discussion on ivermectin, raising questions about transparency, data access, and healthcare rights in the United States. Once a peripheral topic, ivermectin is now at the intersection of public health policy, archival data access, and patient advocacy. This article explores how restored resources, data-driven policies, and access debates...